drugset / Trial / NCT03766425
Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.
RandomizedParallel-groupSingle-blindTreatment
Summary
Comparison of efficacy and safety of Mitomycin and Aflibercept used to support primary trabeculectomy - a prospective, randomized trial in patients with open-angle glaucoma undergoing surgery.
Timeline
- Start
- 2017-06-14
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | 0.05 ml | Other |
| Subject | Aflibercept | Protein / enzyme biologic | 40 mg/ml | Other |
| Comparator | Mitomycin C | Other / unclassified | 0.3 mg/ml | Other |